MedAI Verdict
All comparisons

Artera vs Sectra Pathology

Artera's homepage says the test is fully reimbursed for Medicare patients and that many commercial plans cover it, and the vendor says results come back within 1 to 2 days of specimen receipt. It also calls itself the first and only AI test included in the NCCN Clinical Practice Guidelines. The ordering clinician treats prostate or breast cancer, and Artera lists no public price.

Sectra sells an enterprise image management system through a contact form, also with no public price. Its Digital Pathology Module (K232208, April 16, 2024) is cleared for primary diagnosis of FFPE slides scanned on a Leica Aperio GT 450 DX with a specified Dell display, in SVS and DICOM formats. Sectra's press release calls it the first FDA clearance to allow DICOM pathology images for diagnosis. A hospital pathology department going digital would run it, with IDS7 providing worklists, reporting and image review.

An oncologist orders ArteraAI as a test, and a pathology department installs Sectra as software.

Pathology · Reviewed November 2, 2026

Artera logo

Artera

by Artera

AI risk scores from H&E slides for prostate and breast cancer, run by a CLIA lab. ArteraAI Prostate software is FDA De Novo authorized.

Digital pathology image management (Sectra IDS7) with a marketplace for third-party AI apps. Sectra does not make the AI.

When to pick each one

Artera

  • Vendor says Medicare fully reimburses the test
  • Vendor says results in 1 to 2 days
  • Breast K254115 and prostate DEN240068 on FDA record
Read the full Artera review

Sectra Pathology

  • Digital Pathology Module cleared as K232208
  • Cleared for primary diagnosis with Aperio GT 450 DX
  • Worklists, reporting and image review in IDS7
Read the full Sectra Pathology review

Score

Each row shows points earned of points available under the published rubric.

Artera

65of 100

Top-ranked

Sectra Pathology

33of 100

Competitive
Score by dimension for Artera and Sectra Pathology
DimensionArteraSectra PathologyDifference
FDA clearance18 / 1818 / 180
HIPAA / SOC2 / BAA10 / 100 / 10+10
EHR integrations (count)0 / 4.20 / 4.20
Top-3 EHR coverage (Epic / Oracle / Athena)0 / 2.40 / 2.40
Peer-reviewed papers14.7 / 210 / 21+14.7
RCT / meta-analysis / systematic review7.8 / 7.80 / 7.8+7.8
Funding & adoption signal3 / 128.4 / 12-5.4
Pricing transparency2.5 / 52.5 / 50
Years in market0 / 60 / 60

Scroll horizontally to see every column.

How scores are computed

Pricing

Artera

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price.

Sectra Pathology

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price. Contact form only.

Compliance and integrations

Documented from each vendor’s own pages.

SpecArteraSectra Pathology
Free tierNo / unverifiedNo / unverified
HIPAAYesNo / unverified
SOC 2 Type IIYesNo / unverified
EHR integrationsNot specifiedNot specified
Foundedn/an/a
HQUSSE

Scroll horizontally to see both columns.

Common questions

Open the full pathology comparison

Digital pathology workflows with FDA-cleared cancer detection (prostate, breast, colon), IHC scoring (HER2, Ki67), and AI-powered image management. Tempus, PathAI, Proscia dominate.